Info

The Tony Robbins Podcast

“Why live an ordinary life, when you can live an extraordinary one?” Tony Robbins, the #1 Life and Business Strategist, has helped over 50 million people from 100 countries create real and lasting change in their lives. In this podcast, he shares proven strategies and tactics so you, too, can achieve massive results in your business, relationships, health and finances. In addition to excerpts from his signature events and other exclusive, never-before-released audio content, Tony and his team also conduct deeply insightful interviews with the most prominent masterminds and experts on the global stage.
RSS Feed
The Tony Robbins Podcast
2020
September
June
May
April
March
February
January


2019
December
November
October
September
August
July
June
May
April
March
February
January


2018
December
November
October
September
August
July
May
April
March
February
January


2017
December
November
October
September
August
July
June
May
April
March
February
January


2016
December
November
October
September
August
July
June
May
April
March


All Episodes
Archives
Now displaying: Page 1
Apr 23, 2020

If you are like many people, you’re trying to make sense of all the information about coronavirus that is being shared 24 hours a day on television, headline news, and across social media channels around the world.

It’s a lot to keep up with and comprehend as new numbers and statistics about COVID-19 are being broadcast around the clock. In this episode, we’re bringing you two long-time, leading physicians to provide context and clarification of the facts.

Dr. Peter Diamandis and Dr. Bob Hariri will break down the coronavirus data you’re seeing and hearing from the media. Dr. Hariri, a surgeon, biomedical scientist and serial entrepreneur in biomedical technology will also share some of his team’s breakthroughs in a stem cell treatment that could prove to be an effective solution for COVID-19.

This interview was recorded Thursday, April 9.

0 Comments
Adding comments is not available at this time.